Incyte Corporation
(NASDAQ : INCY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.09%203.001.2%$406.48m
GILDGilead Sciences, Inc.
0.51%73.150.9%$396.47m
CELGCelgene Corporation
0.68%87.791.2%$341.43m
BIIBBiogen Inc.
0.27%335.311.2%$274.71m
ILMNIllumina, Inc.
1.50%352.433.5%$256.03m
REGNRegeneron Pharmaceuticals, Inc.
-0.14%385.972.6%$209.96m
EXASExact Sciences Corporation
-1.66%72.1125.3%$195.38m
VRTXVertex Pharmaceuticals Incorporated
0.59%176.831.9%$160.81m
SRPTSarepta Therapeutics, Inc.
0.92%153.7516.4%$126.02m
AAgilent Technologies, Inc.
-0.46%68.761.5%$120.93m
ALXNAlexion Pharmaceuticals, Inc.
1.58%119.672.0%$109.19m
NKTRNektar Therapeutics
0.50%58.605.6%$96.44m
ALNYAlnylam Pharmaceuticals, Inc
0.42%93.759.7%$96.22m
BMRNBioMarin Pharmaceutical Inc.
1.00%99.134.4%$91.59m
INCYIncyte Corporation
0.73%67.512.5%$88.35m

Company Profile

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.